Thanh bên bài viết

PDF
Ngày xuất bản: 25/11/2024
Số lượt xem tóm tắt: 203
Số lượt xem PDF: 41
DOI: 10.58490/ctump.2024i8TA.2656
Số xuất bản
Số 8TA (2024)
Chuyên mục
Bài báo
Trích dẫn bài báo
Pham, M. C., Le, H. P., Le, T. V., Lam, V. H., Huynh, M. D., Le, D. T. T., & Thach, T. H. T. (2024). TUMOUR-RELATED COMPLICATIONS IN PATIENTS WITH STAGE IV COLORECTAL CANCER TREATED WITH CHEMOTHERAPY WITHOUT PRIMARY TUMOR RESECTION. Tạp chí Y Dược học Cần Thơ, 8TA, 30-36. https://doi.org/10.58490/ctump.2024i8TA.2656

TUMOUR-RELATED COMPLICATIONS IN PATIENTS WITH STAGE IV COLORECTAL CANCER TREATED WITH CHEMOTHERAPY WITHOUT PRIMARY TUMOR RESECTION

Pham Minh Chien1, , Le Hoang Phuc1, Le Thanh Vu1, Lam Vinh Hao1, Huynh Minh Dong2, Le Duong Tan Truong1, Thach Thi Hoai Thuong2
1 Can Tho University of Medicine and Pharmacy
2 Can Tho University of Medicine and Pharmacy Hospital

Nội dung chính của bài viết

Tóm tắt

  Background: Although the typical treatment of patients with stage IV colorectal cancer comprises removal of the primary tumor followed by chemotherapy, some studies suggest that in patients with limited symptoms, the first and only treatment should be chemotherapy. Objectives: To evaluate the complications related to the primary tumor in patients with stage IV colorectal cancer treated with chemotherapy without surgery. Materials and methods: This was a retrospective descriptive study, including 28 patients with stage IV colorectal cancer treated with chemotherapy without primary tumor resection. Results: The average age was 61.4 ± 10.7 years (range 30 - 83) and all of them had the performance status of 0-1. During follow-up, four (14.4%) patients experienced complications. Intestinal obstruction was the most common complication in 3 (10.7%) and there was one case of rectovaginal fistula. Emergency procedures were performed on these patients. The rate of complications was higher in patients with peritoneal metastases than in those without. Conclusions: The incidence of major intestinal complications in colorectal cancer patients with unresected metastases is low. Most patients with stage IV colorectal cancer benefit from chemotherapy rather than surgery.  

Từ khóa

Colorectal cancer, chemotherapy, surgery, complications

Chi tiết bài viết

Tài liệu tham khảo

1. De Haas R..J., Wicherts D.A., Andreani P., Pascal G., Saliba F., et al., Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg. 2011. 253(6), 1069-1079, https://doi.org/10.1097/SLA.0b013e318217e898.
2. De Mestier L., Neuzillet C., Pozet A., Desot E., Deguelte-Lardière S., et al. Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience. Eur J Surg Oncol. 2014. 40(6), 685-691, http:// doi: 10.1016/j.ejso.2014.02.236.
3. Kim C.W., Baek J.H., Choi G.S., Yu C.S., Kang S.B., et al. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trial. Trials. 2016. 17, 34, https://doi.org/10.1186/s13063016-1164-0.
4. Goldberg R.M., Sargent D.J., Morton R.F., Fuchs C.S., Ramanathan R.K., et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004. 22(1): 2330, http:// doi: 10.1200/JCO.2004.09.046.
5. Tournigand C., André T., Achille E., Lledo G., Flesh M., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004. 22(2), 229-237, http:// doi: 10.1200/JCO.2004.05.113.
6. Cook A.D., Single R., and McCahill L.E. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol. 2005. 12(8), 637-645, http:// doi: 10.1245/ASO.2005.06.012.
7. Kleespies A., Füessl K.E., Seeliger H., Eichhorn M.E., Müller M.H., et al. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis. 2009. 24(9), 1097-1109, http:// doi: 10.1007/s00384-009-0734-y.
8. Eisenhauer E.A., Therasse P., Bogaerts J., Schwartz L.H., Sargent D., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009. 45(2), 228-247, http:// doi: 10.1016/j.ejca.2008.10.026.
9. Ferlay J, et al. Global Cancer Observatory: Viet Nam (GLOBOCAN 2022). 2024. https://gco.iarc.who.int/today.
10. Clancy C., Burke J.P., Barry M., Kalady M.F., and Coffey J.C. A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival. Ann Surg Oncol. 2014. 21(12): 3900-3908, http:// doi: 10.1245/s10434-014-3805-4.
11. Simillis C., Kalakouti E., Afxentiou T., Kontovounisios C., Smith J.J., et al. Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis. World J Surg. 2019. 43(7), 1829-1840, http:// doi: 10.1007/s00268019-04984-2.
12. Benson A.B., Venook A.P., Al-Hawary M.M., Arain M.A., Chen Y.J., et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021. 19(3), 329-359, http:// doi: 10.6004/jnccn.2021.001.
13. Aslam M.I., Kellar A., Sharpe D., and Jameson J.S. Ten years experience of managing the primary tumours in patients with stage IV colorectal cancers. Int J Surg. 2010. 8(4), 305-313, http:// doi: 10.1016/j.ijsu.2010.03.005.
14. Ruo L., Gougoutas C., Paty P.B., Guillem J.G., Cohen A.M., et al. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg. 2003. 196(5), 722-728, http:// doi: 10.1016/S1072-7515(03)00136-4.
15. Tebbutt N.C., Norman A.R., Cunningham D., Hill M.E., Tait D., et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut. 2003. 52(4), 568-573, http:// doi: 10.1136/gut.52.4.568.
16. Cáceres M., Pascual M., Alonso S., Montagut C., Gallén M., et al. Treatment of colorectal cancer with unresectable metastasis with chemotherapy without primary tumor resection: analysis of tumor-related complications. Cir Esp. 2014. 92(1), 30-37, http:// doi: 10.1016/j.ciresp.2013.04.015.
17. Benoist S., Pautrat K., Mitry E., Rougier P., Penna C., et al. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg. 2005. 92(9), 11551160, http:// doi: 10.1002/bjs.5060.
18. McCahill L.E., Yothers G., Sharif S., Petrelli N.J., Lai L.L., et al. Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. J Clin Oncol. 2012. 30(26), 3223-3228, http:// doi: 10.1200/JCO.2012.42.4044.
19. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004. 350(23), 2335-2342, http:// doi: 10.1056/NEJMoa032691.